What this video covers
A video from ARDD, posted on Oct 21, 2026. It is about the science of aging.
It comes from a research institute, foundation or scientific meeting on aging. We link to it; we don't make or endorse it. Research stages on this site come from published studies, not from videos.
From the video's description
Matthew O'Connor, Cyclarity Therapeutics, presents at the 13th Aging Research and Drug Discovery Meeting: Removing Oxidized Cholesterol: Clinical Trials for a New Approach to Cardiometabolic and Age-Related Disease Key takeaway: An engineered cyclodextrin dimer selectively clears oxidized cholesterol and reverses foam cells; Phase 1 showed excellent safety and dose-dependent target engagement. The Aging Research and Drug Discovery (ARDD) meeting is the world's leading conference dedicated to longevity biotechnology. It convenes top researchers, pharmaceutical executives, regulators, entrepreneurs, and investors to accelerate the translation of aging science into next-generation medicines. ARDD was founded by Alex Zhavoronkov in 2014. Following years of growth in Europe, ARDD made its North American debut in Boston at the David Rubenstein Treehouse at Harvard University on October 1-3,…
Written by ARDD on YouTube.
More videos like this
Research instituteKejun (Albert) Ying at ARDD2026: An open world model for human health and mortalityThe science of aging
Research instituteHao Pei at ARDD2026: Aging Is Multidimensional — So Must Be the DataThe science of aging
Research instituteYuancheng (Ryan) Lu at ARDD2026: Functional Genomics and Virtual ScreeningThe science of aging
Research instituteCapital Markets and Philanthropy Panel at ARDD2026: What does AI in Longevity Biotech really need?The science of aging